InvestorsHub Logo
Followers 4
Posts 197
Boards Moderated 0
Alias Born 10/18/2013

Re: rafunrafun post# 139633

Wednesday, 08/29/2018 4:40:37 PM

Wednesday, August 29, 2018 4:40:37 PM

Post# of 428712
RAF,

This is a fun game to play. IMO, the BEST case scenario for the day of the announcement is $8-9. Why? I think there is way too much overhead supply that is chomping at the bit to get out. THat, coupled with some uncertainties about “next steps” will prevent us from meteorically rising. Remember, you are the rare retail investor that’s done your homework... You get the science, you believe in the future value of the company, you get what the market potential could be, etc. Most investors will see their shares double overnight and think “EUREKA! I’ve made a fortune! I need to sell and find the next one!” This, coupled with funds that trade according to “size & style” philosophies, will create a good bit of profit taking (or break even selling) on V-Day.

Once the initial dust settles, I believe we will gravitate to the actual market cap that is representative of the future opportunity AMRN presents. Seriously no reason why we can’t be $15-20 by end of year. Personally, I like Gabor’s estimate of $36 smile. As more data points come out, we will go up. As docs learn about the data and start to prescribe in droves, we go up. As Wall Street gains confidence in the business plan that AMRN has laid out to capitalize on this, we go up. They aren’t going to give us our full credit until the company proves that it can monetize the data to its advantage in a way that makes sense to attribute a FORWARD LOOKING multiple to the stock.

What we do know is that Wall St. hates uncertainty. The trial is blinded. No one knows a thing, despite what most are thinking at this point. Bets are on the table and the cards will fall for us or against us. We have traded like an option for years now. I’m personally manifesting a positive outcome smile

Best of Luck,
Cam
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News